Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'neuropeptide y 13 36 porcine'

Search results for: 'neuropeptide y 13 36 porcine'

Items 11-20 of 34

Page
per page
  1. LY335979 (Zosuquidar 3HCL)
    A8549 LY335979 (Zosuquidar 3HCL)
     1 Citation
    Target: P-glycoprotein (P-gp)
    Summary: Pgp (P-glycoprotein) inhibitor
      insoluble in EtOH; ≥17.1 mg/mL
  2. Faropenem daloxate
    A3411 Faropenem daloxate
    Summary: Oral penem,beta-lactam antibiotic
      Soluble in DMSO
  3. GSK2606414
    A3448 GSK2606414
     4 Citation
    Summary: PERK inhibitor,potent and selective
      ≥22.57 mg/mL
  4. GM 6001
    A4050 GM 6001
     2 Citation
    Target: MMP
    Summary: Broad spectrum MMP inhibitor
      insoluble in H2O; insoluble in EtOH; ≥19.42 mg/mL
  5. BRL 50481
    B6988 BRL 50481
    Target: Phosphodiesterases (PDEs)
    Summary: PDE7 inhibitor,potent and selective
      Soluble in DMSO
  6. ProTx II
    B5515 ProTx II
    Target: Voltage-gated Sodium (NaV) Channels
    Summary: NaV1.7 channel blocker
      Soluble to 1 mg/mL
  7. LRRK2-IN-1
    A3558 LRRK2-IN-1
     1 Citation
    Target: LRRK2|DCLK2
    Summary: LRRK2 inhibitor,cell-permeable and ATP competitive
      ≥28.55 mg/mL
  8. PLX-4720
    A3016 PLX-4720
     1 Citation
    Target: Raf
    Summary: BRAF kinase inhibitor
      ≥20.69 mg/mL
  9. Regorafenib
    A8236 Regorafenib
     4 Citation
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: Inhibitor of VEGFR/PDGFR/FGFR/mutant kit/RET/Raf-1
      ≥25.04 mg/mL
  10. MDV3100 (Enzalutamide)
    A3003 MDV3100 (Enzalutamide)
     12 Citation
    Target: Androgen Receptors
    Summary: Androgen receptor antagonist
      ≥23.22 mg/mL

Items 11-20 of 34

Page
per page
Shop By
Now Shopping by
  1. Specificity Selective Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Lab Reagents 1 item
Reversibility
  1. Reversible 1 item
Target
  1. Histone Deacetylases (HDACs) 2item
  2. Akt 1 item
  3. PI3K 3item
  4. Raf 2item
  5. Aurora Kinases 1 item
  6. mTOR 2item
  7. MMP 2item
  8. Androgen Receptors 1 item
  9. FLT3 1 item
  10. P-glycoprotein (P-gp) 1 item
  11. PLK 1 item
  12. Eph Receptors 1 item
  13. VEGFR 4item
  14. PDGFR 4item
  15. c-Kit 2item
  16. RET 1 item
  17. Phosphodiesterases (PDEs) 1 item
  18. Bcr-Abl 1 item
  19. FGFR 2item
  20. Voltage-gated Sodium (NaV) Channels 1 item
  21. Src 1 item
  22. ROCK 1 item
  23. DNA-PK 2item
  24. HSP90 1 item
  25. LRRK2 1 item
  26. Glutamate (Metabotropic) Group I Receptors 1 item
  27. NPY Receptors 1 item
  28. Na /K ATPases 1 item
  29. P110 1 item
  30. Hck 1 item
  31. Catechol O-Methyltransferase (COMT) 1 item
  32. angiogenesis 1 item
  33. Histone Acetyltransferases (HATs) 1 item
  34. NOD1 1 item
  35. DCLK2 1 item
  36. gp120/CD4 1 item
  37. ATM 1 item
Related Disease
  1. Adrenocortical Carcinoma 1 item
  2. Bladder Cancer 1 item
  3. Brain Injuries Studies 1 item
  4. Breast Cancer 4item
  5. Cancer 17item
  6. Chronic Lymphocytic Leukemia 2item
  7. Chronic Myeloproliferative Disorders 1 item
  8. Clear Cell Renal Cell Carcinoma 1 item
  9. Cocaine-Related Disorders 1 item
  10. Colon Cancer 1 item
  11. Colorectal Cancer 3item
  12. Glioblastoma 2item
  13. Glioma 2item
  14. HIV 1 item
  15. Lung Cancer 1 item
  16. Lymphoma 1 item
  17. Multiple Myeloma 3item
  18. Myelofibrosis 1 item
  19. Neuroblastoma 3item
  20. Neurocognitive Disorders 1 item
  21. Non-small Cell Lung Carcinoma 1 item
  22. Obsessive-Compulsive Disorder 1 item
  23. Osteoporosis 1 item
  24. Ovarian Cancer 2item
  25. Pancreatic Cancer 1 item
  26. Prostate Cancer 2item
  27. Pulmonary Fibrosis 1 item
  28. Renal Cancer 1 item
  29. Schizophrenia 1 item
  30. Soft Tissue Sarcoma 1 item
  31. Thyroid Cancer 1 item